Dynamic Evolution of Regional Ecological Services Based on TM Remote Sensing

针对传统评估区域生态系统服务价值空间异质性的问题,本研究将TM遥感影像与价值评估法相结合,测算出针对研究区域的当量因子表,并建立了只需遥感影像数据即可快速并较为精准地动态计算区域生态系统服务价值的多元回归模型。文章以北京市永定河、厦门市和青海省不同尺度为例,对该方法评估区域生态系统服务价值的可行性和准确性进行了讨论,以期为生态综合管理提供定量化参考依据。This paper discussed the dynamic evaluating of regional ecological services with remote sensing technique,based on the comprehensive analysis the character of indexes method and currently equivalent method applying to regional ecological services.With the established method in the literature,it discussed the practical possibility for evaluation the temporal and special regional ecological services in Yongding River,Xiamen and Qinghai province.Compared with the traditional static indexes evaluation,our method discussed the possibility of dynamically evolutional evaluation,in order to provide reference of ecosystem management.北京市科学技术委员会“永定河生态修复目标体系研究”(D090409004009003);北京市生态学重点学科项

褶累枝虫16SrRNA基因分析

以缘毛目褶累枝虫为研究材料，探索和建立了适用于较难培养的单细胞原生动物的分子生物学研究方法，并测定了褶累枝虫１６ＳｒＲＮＡ基因３‘端１１１５个核苷酸，通过比较分析，从分子水平探讨了累枝虫属与缘毛目其它属之间的亲缘关系，为进一步重构原生动物的系统图了基本的资料

褶累枝虫16SrRNA基因分析

以缘毛目褶累枝虫为研究材料，探索和建立了适用于较难培养的单细胞原生动物的分子生物学研究方法，并测定了褶累枝虫１６ＳｒＲＮＡ基因３‘端１１１５个核苷酸，通过比较分析，从分子水平探讨了累枝虫属与缘毛目其它属之间的亲缘关系，为进一步重构原生动物的系统图了基本的资料

褶累枝虫16SrRNA基因分析

以缘毛目褶累枝虫为研究材料，探索和建立了适用于较难培养的单细胞原生动物的分子生物学研究方法，并测定了褶累枝虫１６ＳｒＲＮＡ基因３‘端１１１５个核苷酸，通过比较分析，从分子水平探讨了累枝虫属与缘毛目其它属之间的亲缘关系，为进一步重构原生动物的系统图了基本的资料

褶累枝虫16S rRNA基因分析

以缘毛目褶累枝虫为研究材料，探索和建立了适用于较难培养的单细胞原生动物的分子生物学研究方法．并测定了褶累枝虫１６ＳｒＲＮＡ基因３′端１１１５个核苷酸．通过比较分析，从分子水平探讨了累枝虫属与缘毛目其它属之间的亲缘关系，为进一步重构原生动物的系统图提供最基本的资料

Evaluation Model and Application of Ecosystem Service Valua Based on TM Remote Sensing in Yongding River

针对常规生态服务价值评估方法时间长、工作量大、成本高和当量精度低的问题,永定河生态系统服务价值时空动态分析突破了传统静态评估方法。将gIS技术与因子当量表法相结合,测算出针对永定河河流生态系统的因子当量表和单位面积生态服务价值表,通过线性优化模型计算不同情景下各类土地利用类型面积,以期为生态修复目标提供直接的定量化参考依据。测算永定河北京段总当量为124.91,每当量单位面积生态服务价值基准为2 001.54万元/kM2。林地、草地、耕地、水面和其他土地利用类型单位面积生态服务价值依次为28 824.7、2 954.3、1 808.5、215 906.3和565.8万元/kM2,其中水生态系统文化娱乐服务功能单位面积服务价值最大,为161 735.1万元/kM2。据此,建立了只需遥感影像数据即可快速精准地动态计算区域生态系统服务价值的多元一次回归模型,与基于实地调查法的永定河历史评估结果进行比较,平均偏差为4.54%。利用线性规划方法计算出研究区域生态系统服务价值最大值为2 212亿元,最小值为513亿元;当永定河水面面积最大时,生态系统服务价值为2 212亿元,水面面积最小时生态系统服务价值为976亿元,大于未经优化配置时的432亿元。To improvement the disadvantage of traditional static evaluation,including long period work,mass amount of work,high price and low precision,this literature value Yongding river ecosystem services dynamically.By correlating GIS and equivalent weight factor,it calculated ecosystem services value unit area of Yongding River and the ecosystem services value.The model is aimed to provide quantificational evidence for ecosystem restoration.The total equivalent weight factor is 124.91,and the unit value is 2001.54×104 yuan/km2.The unit value per area of forest,meadow,farmland,water and other ecosystem is 28824.7×104,2954.3×104,1808.5×104,215906.3×104 and 565.8×104 yuan/km2 separately.The highest unit price is entertainmental services of water ecosystem which equals to 161735.1×104 yuan/km2.According to these parameter,it is established multi linear equation to calculate the ecosystem services which is compared with the historical investigation value and the average relative deference is 4.54%.Further more,it is established multi regression equation,which caculates the highest value is 2212×108 yuan and the lowest is 513×108 yuan.With the the biggest water area,the value equals to 2212×108 yuan,and 976×108 yuan with the smallest water area correspondingly.北京市科学技术委员会“永定河生态修复目标体系研究”(No.D090409004009003);北京市生态学重点学科项

Aripiprazole versus other atypical antipsychotics for schizophrenia

BACKGROUND: In most western industrialised countries, second generation (atypical) antipsychotics are recommended as first line drug treatments for people with schizophrenia. In this review we specifically examine how the efficacy and tolerability of one such agent - aripiprazole - differs from that of other comparable second generation antipsychotics. OBJECTIVES: To evaluate the effects of aripiprazole compared with other atypical antipsychotics for people with schizophrenia and schizophrenia-like psychoses. SEARCH METHODS: We searched the Cochrane Schizophrenia Group Trials Register (November 2011), inspected references of all identified studies for further trials, and contacted relevant pharmaceutical companies, drug approval agencies and authors of trials for additional information. SELECTION CRITERIA: We included all randomised clinical trials (RCTs) comparing aripiprazole (oral) with oral and parenteral forms of amisulpride, clozapine, olanzapine, quetiapine, risperidone, sertindole, ziprasidone or zotepine for people with schizophrenia or schizophrenia-like psychoses. DATA COLLECTION AND ANALYSIS: We extracted data independently. For dichotomous data we calculated risk ratios (RR) and their 95% confidence intervals (CI) on an intention-to-treat basis based on a random-effects model. Where possible, we calculated illustrative comparative risks for primary outcomes. For continuous data, we calculated mean differences (MD), again based on a random-effects model. We assessed risk of bias for each included study. MAIN RESULTS: We included 12 trials involving 6389 patients. Aripiprazole was compared to olanzapine, risperidone and ziprasidone. All trials were sponsored by an interested drug manufacturer. The overall number of participants leaving studies early was 30% to 40%, limiting validity (no differences between groups).When compared with olanzapine no differences were apparent for global state (no clinically important change: n = 703, 1 RCT, RR short-term 1.00 95% CI 0.81 to 1.22; n = 317, 1 RCT, RR medium-term 1.08 95% CI 0.95 to 1.22) but mental state tended to favour olanzapine (n = 1360, 3 RCTs, MD total Positive and Negative Syndrome Scale (PANSS) 4.68 95% CI 2.21 to 7.16). There was no significant difference in extrapyramidal symptoms (n = 529, 2 RCTs, RR 0.99 95% CI 0.62 to 1.59) but fewer in the aripiprazole group had increased cholesterol levels (n = 223, 1 RCT, RR 0.32 95% CI 0.19 to 0.54) or weight gain of 7% or more of total body weight (n = 1095, 3 RCTs, RR 0.39 95% CI 0.28 to 0.54).When compared with risperidone, aripiprazole showed no advantage in terms of global state (n = 384, 2 RCTs, RR no important improvement 1.14 95% CI 0.81 to 1.60) or mental state (n = 372, 2 RCTs, MD total PANSS 1.50 95% CI -2.96 to 5.96).One study compared aripiprazole with ziprasidone (n = 247) and both the groups reported similar change in the global state (n = 247, 1 RCT, MD average change in Clinical Global Impression-Severity (CGI-S) score -0.03 95% CI -0.28 to 0.22) and mental state (n = 247, 1 RCT, MD change PANSS -3.00 95% CI -7.29 to 1.29).When compared with any one of several new generation antipsychotic drugs the aripiprazole group showed improvement in global state in energy (n = 523, 1 RCT, RR 0.69 95% CI 0.56 to 0.84), mood (n = 523, 1 RCT, RR 0.77 95% CI 0.65 to 0.92), negative symptoms (n = 523, 1 RCT, RR 0.82 95% CI 0.68 to 0.99), somnolence (n = 523, 1 RCT, RR 0.80 95% CI 0.69 to 0.93) and weight gain (n = 523, 1 RCT, RR 0.84 95% CI 0.76 to 0.94). Significantly more people given aripiprazole reported symptoms of nausea (n = 2881, 3 RCTs, RR 3.13 95% CI 2.12 to 4.61) but weight gain (7% or more of total body weight) was less common in people allocated aripiprazole (n = 330, 1 RCT, RR 0.35 95% CI 0.19 to 0.64). Aripiprazole may have value in aggression but data are limited. This will be the focus of another review. AUTHORS' CONCLUSIONS: Information on all comparisons are of limited quality, are incomplete and problematic to apply clinically. Aripiprazole is an antipsychotic drug with a variant but not absent adverse effect profile. Long-term data are sparse and there is considerable scope for another update of this review as new data emerges from the many Chinese studies as well as from ongoing larger, independent pragmatic trials

JUNO Sensitivity on Proton Decay p→νˉK+p\to \bar\nu K^+ Searches

The Jiangmen Underground Neutrino Observatory (JUNO) is a large liquid scintillator detector designed to explore many topics in fundamental physics. In this paper, the potential on searching for proton decay in $p\to \bar\nu K^+$ mode with JUNO is investigated.The kaon and its decay particles feature a clear three-fold coincidence signature that results in a high efficiency for identification. Moreover, the excellent energy resolution of JUNO permits to suppress the sizable background caused by other delayed signals. Based on these advantages, the detection efficiency for the proton decay via $p\to \bar\nu K^+$ is 36.9% with a background level of 0.2 events after 10 years of data taking. The estimated sensitivity based on 200 kton-years exposure is $9.6 \times 10^{33}$ years, competitive with the current best limits on the proton lifetime in this channel

JUNO sensitivity on proton decay p → ν K + searches*

The Jiangmen Underground Neutrino Observatory (JUNO) is a large liquid scintillator detector designed to explore many topics in fundamental physics. In this study, the potential of searching for proton decay in the $p\to \bar{\nu} K^+$ mode with JUNO is investigated. The kaon and its decay particles feature a clear three-fold coincidence signature that results in a high efficiency for identification. Moreover, the excellent energy resolution of JUNO permits suppression of the sizable background caused by other delayed signals. Based on these advantages, the detection efficiency for the proton decay via $p\to \bar{\nu} K^+$ is 36.9% ± 4.9% with a background level of $0.2\pm 0.05({\rm syst})\pm$$0.2({\rm stat})$ events after 10 years of data collection. The estimated sensitivity based on 200 kton-years of exposure is $9.6 \times 10^{33}$ years, which is competitive with the current best limits on the proton lifetime in this channel and complements the use of different detection technologies